Literature DB >> 6897778

[Impaired intestinal absorption of thyroid hormone in a case of Hashimoto's disease with anti-T3 and anti-T4 antibody].

Y Suzuki, E Takeshita, S Kano, S Hirata, S Sato.   

Abstract

A 28 year old woman with Hashimoto's disease was treated with desiccated thyroid and triiodothyronine (T3). She improved steadily during the first 2 to 3 months and thyroidal function tests turned to normal. Then, in spite of continuing treatment, her serum T4 level decreased gradually and she became fatigued. A serum T3 radioimmunoassay manifested an interference pattern suggested anti-T3 antibody in her serum. Ethanol-extracted serum T3 and T4 levels were low in spite of ingestion of desiccated thyroid or synthetic T3 and T4, suggesting intestinal malabsorption of T3 and T4. Antibodies against T3 and T4 were identified in her serum; affinity constants were 1.16 X 10(10) and 8.73 X 10(8) l/mol respectively. After treatment with synthetic T3 and/or T4 for 20 months, the titer of anti-T3 and anti-T4 antibodies decreased, and impaired intestinal absorption of thyroid hormone improved. Then, after desiccated thyroid treatment was reinstituted, the anti-T3 antibody titer again increased and intestinal absorption of thyroid hormone decreased. These results suggest the oral immunization against thyroid hormones. There was associated impairment in intestinal absorption of thyroid hormone presumably secondary to the anti-T3 and anti-T4 antibodies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897778     DOI: 10.1507/endocrine1927.58.12_1487

Source DB:  PubMed          Journal:  Nihon Naibunpi Gakkai Zasshi        ISSN: 0029-0661


  3 in total

Review 1.  Circulating thyroid hormone autoantibodies.

Authors:  S Benvenga; F Trimarchi; J Robbins
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

2.  INSUFFICIENCY OF LEVOTHYROXINE THERAPY IN AUTOIMMUNE HYPOTHYROIDISM: EFFECT OF GLUCOCORTICOID ADMINISTRATION.

Authors:  B Lozanov; D Gorcheva; L B Lozanov; V Koleva; S Refetoff
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

Review 3.  Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

Authors:  M Centanni; S Benvenga; I Sachmechi
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.